Study of Serum Levels, Venous Irritation and Gastrointestinal Side-effects with Intravenous Erythromycin Lactobionate in Patients with Bronchopulmonary Infection
- 1 October 1983
- journal article
- Published by SAGE Publications in Human Toxicology
- Vol. 2 (4), 593-605
- https://doi.org/10.1177/096032718300200404
Abstract
1 Sixteen patients with bronchopulmonary infection received 500 mg erythromycin lactobionate by intravenous infusion every 8 h for 2 days. The duration of infusion was either 30 (8 patients) or 60 min (8 patients). An inline filterset (0.22 μm) was included in the intravenous administration set in 4 patients of each infusion group.Keywords
This publication has 23 references indexed in Scilit:
- Antibiotic Treatment of PneumoniaAustralian and New Zealand Journal of Medicine, 1982
- Intersubject and dose‐related variability after intravenous administration of erythromycin.British Journal of Clinical Pharmacology, 1980
- Biliary excretion of erythromycin after parenteral administration.Published by Wiley ,1979
- In vivo susceptibility of the Legionnaires disease bacterium to ten antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1978
- Plasma concentration/time curve of erythromycin after a 12-hour intravenous infusion of erythromycin lactobionate in manPublished by Oxford University Press (OUP) ,1978
- A comparison of ampicillin, erythromycin and erythromycin with sulphametopyrazine in the treatment of infective exacerbations of chronic bronchitisRespiratory Medicine, 1978
- A new look at erythromycinPublished by Oxford University Press (OUP) ,1977
- Pharmacokinetics and biological availability of erythromycinInfection, 1977
- Intravenous administration of erythromycin: serum, sputum and urine levelsCurrent Medical Research and Opinion, 1976
- Biliary excretion of antibiotics in man.Gut, 1968